[go: up one dir, main page]

WO2003095427A1 - Spiro-ring compound - Google Patents

Spiro-ring compound Download PDF

Info

Publication number
WO2003095427A1
WO2003095427A1 PCT/JP2003/005812 JP0305812W WO03095427A1 WO 2003095427 A1 WO2003095427 A1 WO 2003095427A1 JP 0305812 W JP0305812 W JP 0305812W WO 03095427 A1 WO03095427 A1 WO 03095427A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
spiro
ring compound
hydrogen
formulae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2003/005812
Other languages
English (en)
French (fr)
Inventor
Shiuji Saito
Hiroki Umemiya
Yoichirou Suga
Masakazu Sato
Naoya Kawashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2004508514A priority Critical patent/JPWO2003095427A1/ja
Priority to AU2003235912A priority patent/AU2003235912A1/en
Publication of WO2003095427A1 publication Critical patent/WO2003095427A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/JP2003/005812 2002-05-10 2003-05-09 Spiro-ring compound Ceased WO2003095427A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004508514A JPWO2003095427A1 (ja) 2002-05-10 2003-05-09 スピロ環化合物
AU2003235912A AU2003235912A1 (en) 2002-05-10 2003-05-09 Spiro-ring compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002135988 2002-05-10
JP2002-135988 2002-05-10
JP2002214248 2002-07-23
JP2002-214248 2002-07-23

Publications (1)

Publication Number Publication Date
WO2003095427A1 true WO2003095427A1 (en) 2003-11-20

Family

ID=29422399

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/005812 Ceased WO2003095427A1 (en) 2002-05-10 2003-05-09 Spiro-ring compound

Country Status (3)

Country Link
JP (1) JPWO2003095427A1 (ja)
AU (1) AU2003235912A1 (ja)
WO (1) WO2003095427A1 (ja)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058303A3 (en) * 2004-11-29 2006-12-21 Vertex Pharma Modulators of muscarinic receptors
US7879834B2 (en) 2004-08-19 2011-02-01 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
WO2011060217A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
WO2011060035A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
US8263605B2 (en) 2006-02-22 2012-09-11 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8304423B2 (en) 2006-02-22 2012-11-06 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8367691B2 (en) 2004-08-19 2013-02-05 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
US8916565B2 (en) 2011-02-02 2014-12-23 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
JP2018058874A (ja) * 2010-10-18 2018-04-12 セレニス セラピューティクス ホールディング エスアー コレステロールモビリゼーションに有用な化合物、組成物及び方法
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
JP2022036285A (ja) * 2015-12-02 2022-03-04 アストライア セラピューティクス， エルエルシー ピペリジニルノシセプチン受容体化合物
US11827617B2 (en) 2015-12-02 2023-11-28 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55143980A (en) * 1979-04-27 1980-11-10 Dai Ichi Seiyaku Co Ltd Anti-allergic preparation
EP0431943A2 (en) * 1989-12-08 1991-06-12 Merck & Co. Inc. Nitrogen-containing spirocycles
WO2000034280A1 (en) * 1998-12-09 2000-06-15 Banyu Pharmaceutical Co., Ltd. 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55143980A (en) * 1979-04-27 1980-11-10 Dai Ichi Seiyaku Co Ltd Anti-allergic preparation
EP0431943A2 (en) * 1989-12-08 1991-06-12 Merck & Co. Inc. Nitrogen-containing spirocycles
WO2000034280A1 (en) * 1998-12-09 2000-06-15 Banyu Pharmaceutical Co., Ltd. 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258148B2 (en) 2004-08-19 2012-09-04 Vertex Pharmaceutical Incorporated Spiroindoline modulators of muscarinic receptors
US7879834B2 (en) 2004-08-19 2011-02-01 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
US8497295B2 (en) 2004-08-19 2013-07-30 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
US8367691B2 (en) 2004-08-19 2013-02-05 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
JP2008521825A (ja) * 2004-11-29 2008-06-26 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
WO2006058303A3 (en) * 2004-11-29 2006-12-21 Vertex Pharma Modulators of muscarinic receptors
US8304423B2 (en) 2006-02-22 2012-11-06 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8263605B2 (en) 2006-02-22 2012-09-11 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8232289B2 (en) 2009-11-16 2012-07-31 Eli Lilly And Company Spiropiperidine compounds as ORL-1 receptor antagonists
WO2011060035A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
WO2011060217A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
JP2018058874A (ja) * 2010-10-18 2018-04-12 セレニス セラピューティクス ホールディング エスアー コレステロールモビリゼーションに有用な化合物、組成物及び方法
US10220040B2 (en) 2010-10-18 2019-03-05 Cerenis Therapeutics Holding Sa Compounds, compositions and methods useful for cholesterol mobilization
US8916565B2 (en) 2011-02-02 2014-12-23 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US9511067B2 (en) 2011-02-02 2016-12-06 Vertex Pharmaceuticals Incorporated Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
US9181273B2 (en) 2011-03-14 2015-11-10 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
JP2022036285A (ja) * 2015-12-02 2022-03-04 アストライア セラピューティクス， エルエルシー ピペリジニルノシセプチン受容体化合物
US11827617B2 (en) 2015-12-02 2023-11-28 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds
USRE49825E1 (en) 2015-12-02 2024-02-06 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds
JP7472175B2 (ja) 2015-12-02 2024-04-22 アストライア セラピューティクス， エルエルシー ピペリジニルノシセプチン受容体化合物
JP2024083529A (ja) * 2015-12-02 2024-06-21 アストライア セラピューティクス， エルエルシー ピペリジニルノシセプチン受容体化合物

Also Published As

Publication number Publication date
JPWO2003095427A1 (ja) 2005-09-15
AU2003235912A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
WO2003095427A1 (en) Spiro-ring compound
CA2447640A1 (en) Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage
TW351715B (en) Benzoyl derivatives
WO2005061458A3 (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
EP1679069A4 (en) NEW PIPERIDINE DERIVATIVE
WO2002081428A1 (en) Benzene compound and salt thereof
NZ501319A (en) Carboxy phenyl derivatives useful in the preparation of aniline derivatives
WO2004103977A3 (en) Process for the preparation of pyrimidine derivatives
DE602004018878D1 (de) Cyaninverbindung, optisches Aufzeichnungsmaterial und optisches Aufzeichnungmedium
EP1295867A4 (en) BIPHENYL COMPOUND
WO2005020293A3 (en) Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene
ATE268330T1 (de) Azaidole mit serotonin rezeptor affinität
WO2003078390A8 (fr) Compose phenolique et materiau d'enregistrement contenant ce dernier
MXPA04002569A (es) H6,7-dihidro-5h-pirazolo[1,2-a]pirazol-1-onas espirociclicas que controlan citocinas inflamatorias.
EP0926146A4 (en) CHROMENE COMPOUNDS
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
AU2001269540A1 (en) Serotonin reuptake inhibitors
EP1306369A4 (en) NEW SULFUR COMPOUNDS AND INTERMOLECULAR COMPOUNDS CONTAINING THEM AS A COMPONENT
EP0712398A1 (en) BENZOPYRANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1535920A4 (en) PROCESS FOR PREPARING 1,3-BENZODIOXOL-2-SPIRO-CYCLOALKANE DERIVATIVES
EP1493765A4 (en) ORGANIC POLYMERS WITH EPOXY AND / OR OXETANYL GROUP-CONTAINING SILICON END GROUPS AND METHOD OF PRODUCTION THEREOF
EP1310490A4 (en) GPR14 ANTAGONIST
NO20031046D0 (no) Fremgangsmåte for fremstilling av en substituert imidazopyridinforbindelse
WO2004099130A3 (en) 1,2-diarylimidazoles useful as inhibitors of cox
EP1403268A4 (en) FLUORESCENT PROBE FOR ZINC

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004508514

Country of ref document: JP

122 Ep: pct application non-entry in european phase